651 related articles for article (PubMed ID: 20685398)
1. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
[TBL] [Abstract][Full Text] [Related]
2. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
Fauman EB; Rai BK; Huang ES
Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
[TBL] [Abstract][Full Text] [Related]
3. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
4. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites.
Schmidtke P; Barril X
J Med Chem; 2010 Aug; 53(15):5858-67. PubMed ID: 20684613
[TBL] [Abstract][Full Text] [Related]
5. Drug-like density: a method of quantifying the "bindability" of a protein target based on a very large set of pockets and drug-like ligands from the Protein Data Bank.
Sheridan RP; Maiorov VN; Holloway MK; Cornell WD; Gao YD
J Chem Inf Model; 2010 Nov; 50(11):2029-40. PubMed ID: 20977231
[TBL] [Abstract][Full Text] [Related]
6. Fragment-based ligand discovery.
Fischer M; Hubbard RE
Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
[TBL] [Abstract][Full Text] [Related]
7. Predicting druggable binding sites at the protein-protein interface.
Fuller JC; Burgoyne NJ; Jackson RM
Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive identification of "druggable" protein ligand binding sites.
An J; Totrov M; Abagyan R
Genome Inform; 2004; 15(2):31-41. PubMed ID: 15706489
[TBL] [Abstract][Full Text] [Related]
9. Conserved core substructures in the overlay of protein-ligand complexes.
Finzel BC; Akavaram R; Ragipindi A; Van Voorst JR; Cahn M; Davis ME; Pokross ME; Sheriff S; Baldwin ET
J Chem Inf Model; 2011 Aug; 51(8):1931-41. PubMed ID: 21736376
[TBL] [Abstract][Full Text] [Related]
10. Combining global and local measures for structure-based druggability predictions.
Volkamer A; Kuhn D; Grombacher T; Rippmann F; Rarey M
J Chem Inf Model; 2012 Feb; 52(2):360-72. PubMed ID: 22148551
[TBL] [Abstract][Full Text] [Related]
11. Structure-based maximal affinity model predicts small-molecule druggability.
Cheng AC; Coleman RG; Smyth KT; Cao Q; Soulard P; Caffrey DR; Salzberg AC; Huang ES
Nat Biotechnol; 2007 Jan; 25(1):71-5. PubMed ID: 17211405
[TBL] [Abstract][Full Text] [Related]
12. BEAR, a novel virtual screening methodology for drug discovery.
Degliesposti G; Portioli C; Parenti MD; Rastelli G
J Biomol Screen; 2011 Jan; 16(1):129-33. PubMed ID: 21084717
[TBL] [Abstract][Full Text] [Related]
13. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
Barelier S; Krimm I
Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
Yang SY
Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
[TBL] [Abstract][Full Text] [Related]
15. Structure-based identification of small molecule binding sites using a free energy model.
Coleman RG; Salzberg AC; Cheng AC
J Chem Inf Model; 2006; 46(6):2631-7. PubMed ID: 17125203
[TBL] [Abstract][Full Text] [Related]
16. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
Roughley SD; Hubbard RE
J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
[No Abstract] [Full Text] [Related]
17. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in fragment-based lead discovery.
Schulz MN; Hubbard RE
Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
[TBL] [Abstract][Full Text] [Related]
19. Two 'Golden Ratio' indices in fragment-based drug discovery.
Orita M; Ohno K; Niimi T
Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598
[TBL] [Abstract][Full Text] [Related]
20. Online magnetic bead based dynamic protein affinity selection coupled to LC-MS for the screening of acetylcholine binding protein ligands.
Pochet L; Heus F; Jonker N; Lingeman H; Smit AB; Niessen WM; Kool J
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(20):1781-8. PubMed ID: 21565564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
